Shasun Pharmaceuticals informs about Outcome of Board Meeting

08 Jun 2015 Evaluate

Shasun Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on June 08, 2015, has approved the conversion of 7,100,000 convertible warrants into equity shares of the Company, which were issued on May 30, 2014 to Sequent Scientific Limited, Mumbai, on preferential basis at a price of Rs 110 per share including premium of Rs 108 per share.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.